Xenon Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
A live audio webcast will be available on the investors section of Xenon's website at www.xenon-pharma.com and will be posted for replay following the event.
We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of
Source: Xenon Pharmaceuticals Inc.